RecruitingNot ApplicableNCT06014125

Paramedical Tele-education on Moderate Depressive Episodes

Tele-education in Patients With a Moderate Depressive Episode in Primary Care


Sponsor

University Hospital, Toulouse

Enrollment

220 participants

Start Date

Jan 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Considering that one out of five people may experience depression during the course of their life, and that compliance to anti-depression medication is often not optimal. Psycho-educational interventions are recommended in international clinical practice guidelines for the management of depression. They are the first step in the treatment protocol. Psychoeducation in the treatment of depressive episodes has been shown to be an effective intervention because it reduces depressive symptoms, the risk of relapse or recurrence and improves adherence to treatment. In France, there are only one approved psycho-education programme, but it concerns a population of patients under psychiatric care. No psycho-education programme has yet been carried out or evaluated in France on depressed patients followed up in primary care by their General Practitioner. Recent changes in our healthcare practices, which have required adaptation to the pandemic context, have led to the development of the use of telemedicine. This study aims to evaluate a new and 100% remote educational program adapted to patients ongoing moderate depression and focused on medication adherence, economic gain and patients and professional satisfaction.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing a digital tele-education program delivered by non-physician healthcare workers (such as nurses) to support people recently diagnosed with a moderate depressive episode. The program is conducted online and aims to help patients better understand and manage their depression alongside their general practitioner's care. **You may be eligible if...** - You have been diagnosed with a moderate depressive episode (DSM-5 criteria) - You have recently started an antidepressant within the last 2 months - Your depression can be managed by your general practitioner (with occasional psychiatrist input if needed) - You have internet access at home and can use a computer/digital platform **You may NOT be eligible if...** - You cannot complete questionnaires (e.g., language barriers) - You have already completed a psychoeducation or patient education program for depression - Your depression is severe enough to require direct psychiatric care Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERpsychoeducative program

The tele-education program consists of 5 sessions and is designed to adapt to changes in depressive symptoms over time. Each session will last an average of 60 minutes. They will be scheduled every week for 5 weeks. The first session is devoted to educational diagnosis, with identification of the patient's needs and any barriers to treatment. The second session will focus on personalised hygienic and dietary measures. A third session will focus on identifying the symptoms of depression, with a particular focus on suicidal ideation and the causes of depression. The role of family and friends will also be discussed. A fourth session will be devoted to providing clear information on antidepressants, with particular attention to the duration of treatment. The aim of the final session is to identify what has been learned and to clarify any questions before drawing up a joint summary of the work done, which will be sent to the patient's GP with his or her consent.


Locations(1)

Chu Toulouse

Toulouse, Occitanie, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06014125


Related Trials